$25.40
$0.00 (0.00%)
End-of-day quote: 04/26/2024
NYSE:PFE

Pfizer Annual Report

Year Year 2023 2022 2021 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Rev. Revenue
$58.50B $100.33B $81.29B $48.99B $47.41B $48.37B $48.42B $48.30B $49.27B $65.17B $61.04B $54.66B $51.58B $49.61B $48.85B $52.82B $52.55B $40.83B $40.91B $41.65B
GM % Gross Margin %
58.99% 66.02% 62.28% 86.95% 85.01% 85.02% 83.60% 84.75% 83.19% 78.43% 80.83% 82.63% 82.07% 81.79% 80.84% 77.44% 79.40% 78.27% 80.82% 79.91%
OM Operating Margin
8.99% 38.87% 33.02% 33.53% 30.65% 31.20% 30.09% 34.42% 32.15% 26.96% 30.12% 33.54% 32.99% 31.58% 28.23% 26.69% 28.00% 18.02% 19.90% 23.17%
EPS Earnings Per Share
$0.00 $1.84 $6.58 $4.42 $2.22 $2.95 $3.00 $2.65 $2.40 $2.20 $2.26 $2.22 $2.19 $2.31 $2.23 $2.02 $2.41 $2.20 $2.06 $2.02 $2.12
Div. Dividends
$1.66 $1.61 $1.56 $0.70 $0.76 $0.96 $1.16 $1.28 $0.80 $0.72 $0.80 $0.88 $0.96 $1.04 $1.12 $1.20 $1.28 $1.36 $1.44 $1.52
PR % Payout Ratio %
90.22% 24.47% 35.29% 33.02% 37.62% 46.60% 52.73% 53.11% 39.60% 32.29% 34.63% 40.18% 43.24% 46.02% 50.91% 50.00% 48.30% 45.33% 48.81% 68.47%
Sha. Shares
5,646m 5,616m 5,620m 7,473m 7,361m 7,124m 6,761m 6,746m 8,070m 8,012m 7,575m 7,276m 6,399m 6,291m 6,175m 6,070m 5,979m 5,717m 5,534m 5,567m
OCF Operating Cash Flow
$0.00M $29.27B $32.58B $16.34B $14.73B $17.59B $13.35B $18.24B $16.59B $11.45B $20.24B $16.75B $17.68B $17.08B $14.69B $16.19B $16.80B $15.83B $12.59B $14.40B
FCF Free Cash Flow
$10.86B $26.03B $29.87B $13.74B $12.63B $15.54B $11.47B $16.54B $15.38B $9.94B $18.58B $15.73B $16.56B $15.68B $13.12B $14.08B $14.51B $13.79B $10.41B $12.15B
FCFS Free Cash Flow Per Share
$0.00 $4.64 $5.33 $1.82 $1.72 $2.15 $1.66 $2.46 $2.20 $1.24 $2.35 $2.06 $2.38 $2.44 $2.14 $2.33 $2.44 $2.33 $1.89 $2.19